2017

Incereb Appoints New Director of Distribution USA/LATM (3rd January 2017)

 

  • Brian Fawcett has been appointed to accelerate growth of a sales distribution network in the USA and Latin America

Dublin based medical device company, Incereb Limited, plans to expand sales activities in the Americas with the appointment of Brian Fawcett as Director of Distribution in USA and Latin America.

Incereb, founded in 2012, has developed a range of EEG Electrode arrays for use in both the Neonatal Intensive Care Unit (NICU) and the ICU. EEG tests are undertaken to detect seizures and electrical abnormalities in brain activity. The Incereb neon™ range of devices significantly reduce the time taken to set up an EEG test and are designed to interface with all existing brands of EEG and CFM equipment.

Brian Fawcett will be responsible for overseeing the growth and development of commercial business activities throughout the Americas, while creating and maintaining effective relationships with authorised distributors already operating in the area. He brings over ten years of strong business experience from various industries and marketing agencies, with a major emphasis in international sales, logistics, and market research in commercial business environments.

James Roche, Incereb founder and CEO, commented on this appointment, “having boots on the ground in the US and Latin America is critical for successful market entry. Brian Fawcett has joined the Incereb team highly recommended and has held similar roles in other companies. The USA and Latin America are vast and, as a Texan, Brian fully understands the challenges posed by distance and coverage, to date he has not disappointed and has already targeted specific groups within these territories”.

About Incereb

Incereb is a venture funded Irish company – investors include ACT Venture Capital Limited, Delta Partners, the Boole Group and Enterprise Ireland (the Irish government organisation responsible for the development and growth of Irish enterprises in world markets).

The company was founded in 2012 by James Roche, CEO, to develop a simpler method of recording neonatal EEG, a traditionally time consuming and complex procedure with which he was very familiar having worked in hospitals in London, Glasgow and Dublin. The company has since moved on to also develop paediatric and adult EEG Electrode arrays as requested by the market. See also www.incereb.com.